azacitidine has been researched along with Seminoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammerpohl, O; Bokemeyer, C; Gillis, AJ; Honecker, F; Looijenga, LH; Oosterhuis, JW; Richter, J; Stoop, H; van Gurp, RJ; Wermann, H | 1 |
| Biermann, K; Gillis, A; Looijenga, LH; Nettersheim, D; Schorle, H | 1 |
2 other study(ies) available for azacitidine and Seminoma
| Article | Year |
|---|---|
Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Cell Differentiation; Cisplatin; DEAD-box RNA Helicases; DNA Methylation; DNA, Neoplasm; Drug Resistance, Neoplasm; Female; Fetus; Gene Expression Regulation, Neoplastic; Germ Cells; Humans; Immunoenzyme Techniques; Infant; Male; Neoplasm Proteins; Neoplasms, Germ Cell and Embryonal; Ovary; Reverse Transcriptase Polymerase Chain Reaction; Seminoma; Testicular Neoplasms; Testis | 2010 |
The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.
Topics: Apoptosis; Azacitidine; Cell Differentiation; Cell Line, Tumor; Decitabine; Depsipeptides; Down-Regulation; Drug Resistance, Neoplasm; Endoderm; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Histone Deacetylases; Homeodomain Proteins; Humans; Male; Nanog Homeobox Protein; Octamer Transcription Factor-3; Seminoma; SOXF Transcription Factors; Testicular Neoplasms; Transcription Factor AP-2; Tranylcypromine; Tretinoin; Up-Regulation | 2011 |